PREDICTING RESPONSE TO RECOMBINANT-HUMAN-ERYTHROPOIETIN - RESPONSE

被引：2

作者：

ABELS, RI ^{[1
]}

HENRY, DH ^{[1
]}

机构：

[1] GRAD HOSP PHILADELPHIA, PHILADELPHIA, PA 19146 USA

来源：

ANNALS OF INTERNAL MEDICINE | 1993年 / 119卷 / 01期

关键词：

D O I：

10.7326/0003-4819-119-1-199307010-00018

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：91 / 92

页数：2

共 3 条

[1]

ABELS RI, 1991, BLOOD CELL GROWTH FACTORS : THEIR PRESENT AND FUTURE USE IN HEMATOLOGY AND ONCOLOGY, P121

[2] RECOMBINANT-HUMAN-ERYTHROPOIETIN IN THE TREATMENT OF ANEMIA ASSOCIATED WITH HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) INFECTION AND ZIDOVUDINE THERAPY - OVERVIEW OF 4 CLINICAL-TRIALS [J].

HENRY, DH ;

BEALL, GN ;

BENSON, CA ;

CAREY, J ;

CONE, LA ;

ERON, LJ ;

FIALA, M ;

FISCHL, MA ;

GABIN, SJ ;

GOTTLIEB, MS ;

GALPIN, JE ;

GROOPMAN, JE ;

HOOTON, TM ;

JEMSEK, JG ;

LEVINE, RL ;

MILES, SA ;

RINEHART, JJ ;

RIOS, A ;

ROBBINS, WJ ;

RUCKDESCHEL, JC ;

SMITH, JA ;

SPRUANCE, SL ;

STARRETT, B ;

TONEY, J ;

ZALUSKY, R ;

ABELS, RI ;

BRYANT, EC ;

LARHOLT, KM ;

SAMPSON, AR ;

RUDNICK, SA .

ANNALS OF INTERNAL MEDICINE, 1992, 117 (09) :739-748

[3]

STEIN RS, 1991, BLOOD, V78, P1658

← 1 →